Concentration of azapropazone in synovial tissues and fluid. 1987

H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov

The concentration-time curves of azapropazone in synovial fluid and tissues have been studied in arthritic patients after an i.v. bolus (600 mg) and under steady-state conditions. Synovial fluid and tissue samples were taken intraoperatively 0.45-60 h after administration. The azapropazone concentrations in synovial fluid, synovial tissue and plasma were correlated. The levels in synovial fluid were usually lower than corresponding plasma levels. Under steady-state conditions azapropazone did not accumulate in synovial tissues.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001032 Apazone An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout. Azapropazone,5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione,Apazone Dihydrate,Prolixan,Rheumox,Tolyprin,Dihydrate, Apazone
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
October 1959, Clinical chemistry,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
July 1992, The Journal of rheumatology,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
April 2007, The Journal of antimicrobial chemotherapy,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
August 1982, Clinical orthopaedics and related research,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
November 2016, Biorheology,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
May 1961, Nature,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
January 1974, Scandinavian journal of rheumatology,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
October 1990, American journal of veterinary research,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
December 1989, American journal of veterinary research,
H Spahn, and K Thabe, and E Mutschler, and K Tillmann, and I Gikalov
November 2016, Biorheology,
Copied contents to your clipboard!